170 related articles for article (PubMed ID: 28791752)
1. Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia.
Reddel HK; Beckert L; Moran A; Ingham T; Ampon RD; Peters MJ; Sawyer SM
Respirology; 2017 Nov; 22(8):1570-1578. PubMed ID: 28791752
[TBL] [Abstract][Full Text] [Related]
2. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β
Pavord ID; Mathieson N; Scowcroft A; Pedersini R; Isherwood G; Price D
NPJ Prim Care Respir Med; 2017 Mar; 27(1):17. PubMed ID: 28270657
[TBL] [Abstract][Full Text] [Related]
3. Asthma control in patients treated with inhaled corticosteroids and long-acting beta agonists: A population-based analysis in Germany.
Kondla A; Glaab T; Pedersini R; Lommatzsch M
Respir Med; 2016 Sep; 118():58-64. PubMed ID: 27578472
[TBL] [Abstract][Full Text] [Related]
4. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
5. Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study.
Sadatsafavi M; Lynd LD; Marra CA; FitzGerald JM
Thorax; 2014 Apr; 69(4):328-34. PubMed ID: 24281327
[TBL] [Abstract][Full Text] [Related]
6. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
7. One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.
Sadatsafavi M; Lynd LD; De Vera MA; Zafari Z; FitzGerald JM
Respir Med; 2015 Mar; 109(3):320-8. PubMed ID: 25596136
[TBL] [Abstract][Full Text] [Related]
8. Does a Patient-Directed Financial Incentive Affect Patient Choices About Controller Medicines for Asthma? A Discrete Choice Experiment and Financial Impact Analysis.
Laba TL; Reddel HK; Zwar NJ; Marks GB; Roughead E; Flynn A; Goldman M; Heaney A; Lembke K; Jan S
Pharmacoeconomics; 2019 Feb; 37(2):227-238. PubMed ID: 30367400
[TBL] [Abstract][Full Text] [Related]
9. Lack of asthma and rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia.
Bosnic-Anticevich S; Kritikos V; Carter V; Yan KY; Armour C; Ryan D; Price D
J Asthma; 2018 Jun; 55(6):684-694. PubMed ID: 28886264
[TBL] [Abstract][Full Text] [Related]
10. General practitioners' views on the influence of cost on the prescribing of asthma preventer medicines: a qualitative study.
Tudball J; Reddel HK; Laba TL; Jan S; Flynn A; Goldman M; Lembke K; Roughead E; Marks GB; Zwar N
Aust Health Rev; 2019 Jul; 43(3):246-253. PubMed ID: 29754592
[TBL] [Abstract][Full Text] [Related]
11. Adherence to anti-inflammatory treatment for asthma in clinical practice in France.
Latry P; Pinet M; Labat A; Magand JP; Peter C; Robinson P; Martin-Latry K; Molimard M
Clin Ther; 2008; 30 Spec No():1058-68. PubMed ID: 18640480
[TBL] [Abstract][Full Text] [Related]
12. Burden of asthma among patients adherent to ICS/LABA: A real-world study.
Davis J; Trudo F; Siddall J; Small M
J Asthma; 2019 Mar; 56(3):332-340. PubMed ID: 29624458
[TBL] [Abstract][Full Text] [Related]
13. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
Hozawa S; Terada M; Haruta Y; Hozawa M
Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
[TBL] [Abstract][Full Text] [Related]
14. Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
Israel E; Roche N; Martin RJ; Colice G; Dorinsky PM; Postma DS; Guilbert TW; van Aalderen WM; Grigg J; Hillyer EV; Burden A; von Ziegenweidt J; Thomas V; Price DB
Ann Am Thorac Soc; 2015 Jun; 12(6):798-806. PubMed ID: 25756308
[TBL] [Abstract][Full Text] [Related]
15. Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population.
Reddel HK; Sawyer SM; Everett PW; Flood PV; Peters MJ
Med J Aust; 2015 May; 202(9):492-7. PubMed ID: 25971575
[TBL] [Abstract][Full Text] [Related]
16. Long-acting β2-agonist step-off in patients with controlled asthma.
Brozek JL; Kraft M; Krishnan JA; Cloutier MM; Lazarus SC; Li JT; Santesso N; Strunk RC; Casale TB
Arch Intern Med; 2012 Oct; 172(18):1365-75. PubMed ID: 22928176
[TBL] [Abstract][Full Text] [Related]
17. Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.
van Aalderen WM; Grigg J; Guilbert TW; Roche N; Israel E; Martin RJ; Colice G; Postma DS; Hillyer EV; Burden A; Thomas V; von Ziegenweidt J; Price D
J Allergy Clin Immunol Pract; 2015; 3(5):721-31.e16. PubMed ID: 26032474
[TBL] [Abstract][Full Text] [Related]
18. Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial.
Rottenkolber M; Fischer R; Ibáñez L; Fortuny J; Reynolds R; Amelio J; Gerlach R; Tauscher M; Thürmann P; Hasford J; Schmiedl S
BMC Pulm Med; 2015 May; 15():55. PubMed ID: 25943421
[TBL] [Abstract][Full Text] [Related]
19. Real-world effects of two inhaled corticosteroid/long-acting β₂-agonist combinations in the treatment of asthma.
Yatera K; Yamasaki K; Nishida C; Noguchi S; Oda K; Akata K; Nagata S; Kawanami Y; Kawanami T; Ishimoto H; Mukae H
J Asthma; 2014 Sep; 51(7):762-8. PubMed ID: 24654703
[TBL] [Abstract][Full Text] [Related]
20. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
Eltonsy S; Forget A; Beauchesne MF; Blais L
J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
